Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 4/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | MAOA | P21397 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | HPGD | P15428 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 4/20 | 0.40 |
| ▸ | CTSG | P08311 | 4/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3751327 | 1.00 | TRPA1 (0.62) | TRPA1ALDH1A1MAPK1TSHRMAOA | |
| SCHEMBL11967649 | 1.00 | TRPA1 (0.62) | TRPA1ALDH1A1MAPK1TSHRMAOA | |
| SCHEMBL29466168 | 1.00 | TRPA1 (0.62) | TRPA1ALDH1A1MAPK1TSHRMAOA | |
| SCHEMBL17552282 | 0.88 | TRPA1 (0.62) | TRPA1ALDH1A1MAPK1TSHRMAOA | |
| SCHEMBL3763236 | 0.88 | TRPA1 (0.62) | TRPA1ALDH1A1MAPK1TSHRMAOA | |
| SCHEMBL3763234 | 0.88 | TRPA1 (0.62) | TRPA1ALDH1A1MAPK1TSHRMAOA | |
| SCHEMBL30493730 | 0.80 | TRPA1 (0.52) | TRPA1ALDH1A1MAPK1TSHRMAOA | |
| SCHEMBL9145106 | 0.79 | MAOA (0.47) | TRPA1ALDH1A1MAPK1TSHRMAOA | |
| SCHEMBL9145121 | 0.79 | MAOA (0.47) | TRPA1ALDH1A1MAPK1TSHRMAOA | |
| SCHEMBL29466170 | 0.77 | TRPA1 (0.46) | TRPA1ALDH1A1MAPK1TSHRMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1993580-A1 | COMBINATION THERAPY FOR TREATMENT OF PATIENTS WITH NEUROLOGICAL DISORDERS AND CEREBRAL INFARCTION | Moleac Pte Ltd. (SG) | 2008-11-26 | — | — | EP | claimed |
| WO-2007106049-A1 | COMBINATION THERAPY FOR TREATMENT OF PATIENTS WITH NEUROLOGICAL DISORDERS AND CEREBRAL INFARCTION | MOLEAC PTE LTD (SG) | 2007-09-20 | — | — | WO | claimed |
| CN-113791154-B | Method for identifying chemical components in Xuebijing injection | 天津中医药大学 | 2023-06-23 | — | — | CN | disclosed |
| CN-113791154-A | Method for identifying chemical components in Xuebijing injection | 天津中医药大学 | 2021-12-14 | — | — | CN | disclosed |
| US-10987389-B2 | Anti-tumor traditional Chinese medicine microbial fermentation preparation and a preparation method and application thereof | LI XINGYAO (CN) | 2021-04-27 | — | — | US | disclosed |
| CN-112168890-A | Formula and preparation method of quick-acting rescue crude drug for rescuing diseased and dangerous fishes | 王虎 | 2021-01-05 | — | — | CN | disclosed |
| CN-110522798-A | A kind of compound preparation and preparation method thereof curing mainly coronary heart disease | XINJIANG HUACHUN BIOLOGICAL PHARMACEUTICAL CO LTD | 2019-12-03 | — | — | CN | disclosed |
| CN-110179855-A | A kind of therapeutic agent and its formulation preparation method of post-natal depression | 湘潭大学 | 2019-08-30 | — | — | CN | disclosed |
| CN-110179855-A | A kind of therapeutic agent and its formulation preparation method of post-natal depression | 湘潭大学 | 2019-08-30 | — | — | CN | disclosed |
| CN-110150470-A | Chinese herb residues deposit the feed and preparation and feeding method of functional mass into mutton | 吉林农业大学 | 2019-08-23 | — | — | CN | disclosed |
| CN-109646498-A | For treating the Chinese medicine composition of ankylosing spondylitis | 吴蓓莉 | 2019-04-19 | — | — | CN | disclosed |
| CN-102698137-A | Composition with blood pressure reducing function and preparation method of same | JIE WANG | 2012-10-03 | — | — | CN | disclosed |
| US-20100298427-A1 | Anti-inflammatory compositions and their use | DSM IP ASSETS B.V. (NL) | 2010-11-25 | — | — | US | disclosed |
| US-20090176873-A1 | NOVEL USE OF ORGANIC COMPOUNDS | DSM IP ASSETS B.V. (NL) | 2009-07-09 | — | — | US | disclosed |
| US-20090162459-A1 | Combination Therapy for Treatment of Patients with Neurological Disorders and Cerebral Infarction | MOLEAC PTE. LTD (SG) | 2009-06-25 | — | — | US | disclosed |
| EP-1993580-A1 | COMBINATION THERAPY FOR TREATMENT OF PATIENTS WITH NEUROLOGICAL DISORDERS AND CEREBRAL INFARCTION | Moleac Pte Ltd. (SG) | 2008-11-26 | — | — | EP | disclosed |
| WO-2008100977-A2 | CARBAMATES THERAPEUTIC RELEASE AGENTS AS AMIDASE INHIBITORS | N.V. ORGANON (NL) | 2008-08-21 | — | — | WO | disclosed |
| CN-100348227-C | Oral medicine preparation for treating apoplexy and sequela | XI AN SANTAI BIOPHARMACEUTICAL (CN) | 2007-11-14 | — | — | CN | disclosed |
| WO-2007106049-A1 | COMBINATION THERAPY FOR TREATMENT OF PATIENTS WITH NEUROLOGICAL DISORDERS AND CEREBRAL INFARCTION | MOLEAC PTE LTD (SG) | 2007-09-20 | — | — | WO | disclosed |
| CN-1813981-A | Oral medicine preparation for treating apoplexy and sequela | XI AN SANTAI BIOPHARMACEUTICAL (CN) | 2006-08-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176873-A1 | NOVEL USE OF ORGANIC COMPOUNDS | F12, F13B, COL1A1 | TRPA1 309/4885ALDH1A1 703/4885MAPK1 315/4885 |
| US-20100298427-A1 | Anti-inflammatory compositions and their use | COL1A1, COL2A1, F12 | TRPA1 729/4885ALDH1A1 1063/4885MAPK1 190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.